news
Judge Blocks Colorado Amgen Drug Price Cap
A US judge halted a Colorado state panel's move to cap the price of Amgen's blockbuster drug Enbrel. This ruling prevents the state government from setting a price ceiling for the rheumatoid arthritis medication, a win for pharmaceutical companies pushing back on federal and state drug price controls.
A US judge halted a Colorado state panel's move to cap the price of Amgen's blockbuster drug Enbrel. This ruling prevents the state government from setting a price ceiling for the rheumatoid arthritis medication, a win for pharmaceutical companies pushing back on federal and state drug price controls.
The architecture take
The courts just stepped in and said, 'Chill, Colorado.' This isn't just about Amgen; it sets a precedent for every other pharma company wary of states trying to dictate drug prices. Watch for more big pharma pushback as consumers feel the squeeze.